Sandoz
Sandoz, a division of Novartis, is a global leader in the pharmaceutical industry, headquartered in Switzerland (CH). Founded in 1886, Sandoz has established itself as a pioneer in generic and biosimilar medicines, focusing on high-quality, affordable healthcare solutions. With a strong presence in Europe, North America, and emerging markets, the company is dedicated to improving patient access to essential medications. Sandoz's core offerings include a diverse range of generic pharmaceuticals, biosimilars, and over-the-counter products, distinguished by their rigorous quality standards and innovative approaches. The company has achieved significant milestones, including the launch of several groundbreaking biosimilars, solidifying its position as a trusted partner in the healthcare sector. With a commitment to sustainability and patient-centric solutions, Sandoz continues to shape the future of medicine.
DitchCarbon Score
How does Sandoz's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sandoz's score of 58 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sandoz's reported carbon emissions
In 2024, Sandoz, headquartered in Switzerland (CH), reported total carbon emissions of approximately 2,278,340,000 kg CO2e. This figure includes 86,200,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 122,300,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The company also disclosed significant Scope 3 emissions, amounting to about 2,051,700,000 kg CO2e, which includes emissions from the entire value chain, such as purchased goods and services (1,480,000,000 kg CO2e) and upstream transportation and distribution (181,900,000 kg CO2e). Sandoz has committed to near-term climate targets, although it has not set a net-zero target as of now. The company is actively working on its climate commitments within the pharmaceuticals, biotechnology, and life sciences sector, aiming to enhance sustainability and reduce its carbon footprint. The emissions data reflects Sandoz's ongoing efforts to monitor and manage its environmental impact while striving for improvements in its operational efficiency and sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 75,620,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 158,430,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sandoz is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
